Swiss Life Asset Management Ltd

Position in RPRX — Royalty Pharma plc

CIK 1637689 Zurich, V8

Position in RPRX

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$7,641,386

+$3,114,904 QoQ

Shares Held

136,283

+16.3% QoQ

Ownership

0.024%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#174

of 641 holders

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Swiss Life Asset Management Ltd holds $122,705,584 across 67 Biotechnology names. RPRX ranks #5 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	91,614	$45,507,422
2	REGN	Regeneron Pharmaceuticals, Inc.	28,220	$17,596,298
3	INCY	Incyte Corp	104,901	$11,891,577
4	ALNY	Alnylam Pharmaceuticals, Inc.	29,327	$8,828,306
5	RPRX	Royalty Pharma plc This page	136,283	$7,641,386
6	RVMD	Revolution Medicines, Inc.	17,736	$3,321,598
7	INSM	INSMED Inc	27,552	$2,937,594
8	MRNA	Moderna, Inc.	25,088	$1,756,912

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,641,386	136,283	+8.1%	Principal	Defined	2026-07-29
2025-12-31	$4,526,482	117,145	+2.5%	Shares	Defined	2026-02-04
2025-09-30	$4,030,986	114,257	-54.6%	Shares	Sole	2025-12-02
2025-06-30	$4,541,292	126,042	—	Principal	Sole	2025-12-02
2025-03-31	$7,841,023	251,880	+93.3%	Shares	Sole	2025-12-02
2024-12-31	$3,324,054	130,304	+140.3%	Shares	Sole	2025-12-09
2024-09-30	$1,534,053	54,226	+3.8%	Shares	Defined	2025-12-09
2024-06-30	$1,377,225	52,227	-8.1%	Shares	Defined	2025-12-09
2023-06-30	$1,746,800	56,825	0.0%	Shares	Sole	2025-12-09
2023-03-31	$2,047,404	56,825	—	Shares	Sole	2025-12-09
No filing history on record for this holder in this stock.